| |
---|
| Detailed Price Information Link |
BACTERIA | How to read the following data (Example) |
Name: | Hoylesella timonensis Glazunova et al. 2007) Hitch et al. 2023 |
Synonym(s): | Prevotella timonensis Glazunova et al. 2007 emend. Hahnke et al. 2016 |
DSM No.: | 22865, Type strain dsm-22865 dsm22865 dsm 22865 Hoylesella timonensis |
Strain designation: | 4401737 |
Other collection no. or WDCM no.: | CCUG 50105,CIP 108522,JCM 15640 |
Isolated from: | human breast abscess (40-year-old woman) |
Country: | France Marseille |
Date of sampling: | before 27.04.2006 |
Nagoya Protocol Restrictions: | France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.
To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:
1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
2. Await approval by the Ministry for the Ecological Transition, the competent national authority
3. Respond to any requests for more information from the competent national authority
4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.
For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de |
History: | <- CCUG; CCUG 50105 <- V. Roux, Timone Hospital, Marseille, France |
Genbank accession numbers: | 16S rRNA gene: DQ518919 whole genome shotgun sequence: AUMG00000000 |
Cultivation conditions: | Medium 110 , anaerobic, 37°C Medium/media recipe(s) required for preparing 110: - Medium 78
Please follow special instructions: 'Cultivation of Anaerobes'
Complete DSMZ Media List |
Summary and additional information: | <- CCUG; CCUG 50105 <- V. Roux, Timone Hospital, Marseille, France. Human breast abscess (40-year-old woman); France, Marseille. Type strain. Taxonomy/description (10946, 26748, 26962). Sequence accession no. 16S rRNA gene: DQ518919 (10946), whole genome shotgun sequence: AUMG00000000. G+C content 42.4 mol% (26748). (Medium 110, 37°C, anaerobic). |
Literature: | 10946, 26748, 26962 |
Risk group: | 1 (+) (classification according to German TRBA) |
Supplied as: | Delivery form | | Prices | | Freeze Dried | | 100,- € | Active culture on request | | 240,- € | DNA | | 150,- € | | Price Category for this culture: 1 |
Freight and handling charges will be added. See price list. |
Other cultures: | All DSMZ cultures of the species |
| Print data sheet |